Skip to main content
Clinical Trials/NCT01027078
NCT01027078
Terminated
Not Applicable

Mechanism of Endothelial Dysfunction in Obstructive Sleep Apnea

Ohio State University1 site in 1 country90 target enrollmentNovember 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obstructive Sleep Apnea
Sponsor
Ohio State University
Enrollment
90
Locations
1
Primary Endpoint
eNOS Expression
Status
Terminated
Last Updated
3 years ago

Overview

Brief Summary

The investigators hypothesized that patients with Obstructive Sleep Apnea (OSA) who are free of any cardiovascular disease will have early microcirculatory changes that are unique to OSA, and therefore would resolve with treatment of OSA.

Detailed Description

Impaired vascular regulation of the microcirculation is a consequence of Obstructive Sleep Apnea (OSA). Nitric Oxide (NO) related endothelial dysfunction occurs in OSA as the earliest vascular abnormality prior to the manifestation of vascular disease and it results in impaired vasodilatory response to hypoxia. These abnormalities have already been described in OSA patients. The role of oxidative stress in endothelial dysfunction is present in vascular disorders. The presence of oxidative stress in OSA patients is also well established. The effect of increased superoxide on endothelial function has also been described in the literature. The mechanism of this effect is unknown and is the focus of this research. We hypothesized that patients with Obstructive Sleep Apnea (OSA) who are free of any cardiovascular disease will have early microcirculatory changes that are unique to OSA, and therefore would resolve with treatment of OSA.

Registry
clinicaltrials.gov
Start Date
November 2009
End Date
February 4, 2022
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

eNOS Expression

Time Frame: Measured at basline and 3-months post-treatment (CPAP) initiation

All measurements will be obtained upon diagnosis of OSA and 12 weeks after effective treatment with continuous positive airway pressure (CPAP). Controls will receive all measurements at baseline.

Secondary Outcomes

  • Peroxynitrite Formation(Measured at basline and 3-months post-treatment (CPAP) initiation)

Study Sites (1)

Loading locations...

Similar Trials